Literature DB >> 22707135

Chlamydia trachomatis serovar distribution and other sexually transmitted coinfections in subjects attending an STD outpatients clinic in Italy.

Antonella Marangoni1, Claudio Foschi, Paola Nardini, Antonietta D'Antuono, Nicoletta Banzola, Antonietta Di Francesco, Fabio Ostanello, Incoronata Russo, Manuela Donati, Roberto Cevenini.   

Abstract

We studied the prevalence of Chlamydia trachomatis (CT) urogenital infection and the distribution of different genotypes in a non-selected STD population of 1625 patients, evaluating presence of coinfections with other sexually transmitted diseases. Each patient was bled to perform serological tests for syphilis and HIV, then urethral or endocervical swabs were obtained for the detection of CT and Neisseria gonorrhoeae by culture. DNA extracted from remnant positive swabs was amplified by omp1 Nested PCR and products were sequenced. Total prevalence of CT infection was 6.3% (103/1625), with strong differences between men and women (11.4% vs 3.9%, P<0.01). Clinical symptoms and coinfections were much more frequent in men than in women (P<0.01). The most common serovar was E (prevalence of 38.8%), followed by G (23.3%), F (13.5%) D/Da (11.6%) and J (4.8%). Serovars distribution was statistically different between men and women (P=0.042) and among patients with or without coinfection (P=0.035); patients infected by serovar D/Da showed the highest coinfection rate. This study can be considered a contribution in increasing knowledge on CT serovar distribution in Italy. Further studies are needed to better define molecular epidemiology of CT infection and to investigate its correlation with other STDs.

Entities:  

Mesh:

Year:  2012        PMID: 22707135

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  7 in total

1.  Chlamydia trachomatis genotypes in school adolescents, Italy.

Authors:  Paola Stefanelli; Giorgia Sulis; Giovanna Renna; Franco Gargiulo; Paola Zanotti; Michela Capelli; Maria Antonia De Francesco; Francesco Donato; Sergio Pecorelli; Alberto Matteelli
Journal:  Infection       Date:  2015-05-05       Impact factor: 3.553

Review 2.  Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy.

Authors:  S Bianchi; E R Frati; M Canuti; D Colzani; E Fasoli; A Amendola; E Tanzi
Journal:  J Prev Med Hyg       Date:  2016-09

3.  Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology.

Authors:  Marianna Martinelli; Rosario Musumeci; Alberto Rizzo; Narcisa Muresu; Andrea Piana; Giovanni Sotgiu; Fabio Landoni; Clementina Cocuzza
Journal:  Int J Environ Res Public Health       Date:  2019-09-11       Impact factor: 3.390

4.  Effect of Sugars on Chlamydia trachomatis Infectivity.

Authors:  Giacomo Marziali; Antonella Marangoni; Claudio Foschi; Maria Carla Re; Natalia Calonghi
Journal:  Pathogens       Date:  2020-04-17

5.  Chlamydia trachomatis genovar distribution in clinical urogenital specimens from Tunisian patients: high prevalence of C. trachomatis genovar E and mixed infections.

Authors:  Houda Gharsallah; Olfa Frikha-Gargouri; Hanen Sellami; Fatma Besbes; Abir Znazen; Adnene Hammami
Journal:  BMC Infect Dis       Date:  2012-11-30       Impact factor: 3.090

6.  Chlamydia trachomatis, human immunodeficiency virus (HIV) distribution and sexual behaviors across gender and age group in an African setting.

Authors:  Joel Fleury Djoba Siawaya
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

7.  Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant.

Authors:  Sukumar Pal; Salvador Fernando Ausar; Delia F Tifrea; Chunmei Cheng; Scott Gallichan; Violette Sanchez; Luis M de la Maza; Lucian Visan
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.